Yuti Chernajovsky

Molecular engineering of short half-life small peptides (VIP, αMSH and γ3MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics

G. Adams, Rita Jones, T. Montero-Melendez, 2011, Annals of the rheumatic diseases.

Synthesis of human interferon beta 1 in Escherichia coli infected by a lambda phage recombinant containing a human genomic fragment.

J. Weissenbach, U. Nir, Y. Chernajovsky, 1981, European journal of biochemistry.

Historical development of monoclonal antibody therapeutics.

Y. Chernajovsky, A. Nissim, Y Chernajovsky, 2008, Handbook of experimental pharmacology.

Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent

D. Scherman, P. Tak, C. Jorgensen, 2007, Annals of the rheumatic diseases.

Differential effects of two interferon-induced translational inhibitors on initiation of protein synthesis.

A. Zilberstein, A. Kimchi, Y. Chernajovsky, 1979, European journal of biochemistry.